Global Automated Cell Shakers Market Size To Exceed USD 1,471.1 million by 2035 | CAGR of 7.02%: Market Growth Report

Global Automated Cell Shakers Market Insights Forecasts to 2035

• The Global Automated Cell Shakers Market Size Was Estimated at USD 697.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.02% from 2025 to 2035
• The Worldwide Automated Cell Shakers Market Size is Expected to Reach USD 1,471.1 Million by 2035
• Asia Pacific is Expected to Grow the fastest during the forecast period.

Automated Cell Shakers Market

The global automated cell shakers market includes advanced laboratory equipment designed to agitate and mix biological samples and cell cultures with high precision. These systems are essential in ensuring uniform cell growth, enhancing reproducibility, and improving efficiency in laboratory workflows. Automated cell shakers are widely used in pharmaceutical research, biotechnology, regenerative medicine, and academic laboratories. Common product types include orbital shakers, benchtop incubator shakers, and rotary-arm models, with orbital shakers seeing particularly strong demand. The equipment plays a critical role in various applications such as drug discovery, cell therapy, and synthetic biology. The primary end users of automated cell shakers are pharmaceutical companies, contract development and manufacturing organizations (CDMOs), and research institutions, reflecting their widespread integration into both industrial and academic settings.

Attractive Opportunities in the Automated Cell Shakers Market

1. With the increasing focus on biologics, vaccines, and personalized medicine, there’s a rising need for efficient and reliable tools for cell culture and drug testing. Automated cell shakers are crucial in high-throughput screening, drug discovery, and biologic therapy development, presenting significant growth potential in the pharmaceutical sector.
2. The Asia-Pacific region is expected to grow at the fastest rate due to increasing investments in biotechnology, pharmaceutical research, and healthcare infrastructure. Manufacturers can tap into this high-growth market by expanding operations and partnerships in emerging economies like China, India, and Japan.
3. The integration of smart technologies, such as IoT connectivity, remote monitoring, and energy-efficient designs, presents an opportunity to cater to labs looking to improve automation and workflow efficiency. These innovations will drive demand for more advanced, user-friendly automated shakers.
4. Automated cell shakers are finding new applications in synthetic biology, food technology, and environmental research, especially in fermentation and microbial studies. This opens up new markets beyond pharmaceuticals, creating diversification opportunities for manufacturers.

Global Automated Cell Shakers Market Dynamics

DRIVER: Increasing need for faster and more reliable cell culture processes

One major reason is the increasing need for faster and more reliable cell culture processes in research and drug development. Automated cell shakers help labs save time, reduce mistakes, and ensure consistent results. As more work is being done in areas like drug discovery, vaccine production, and cell therapy, the demand for these machines continues to rise. New technologies have also made these shakers more advanced, with features like adjustable speed, temperature control, and compatibility with different types of lab containers. In addition, the growing use of personalized medicine and cell-based treatments means more labs need high-quality tools to grow cells accurately. Companies that offer research and manufacturing services are also adopting automated equipment to meet strict industry standards. Overall, the move toward automation in laboratories is helping drive steady growth in the use of automated cell shakers.

RESTRAINT: High cost of buying and maintaining these machines

One of the main issues is the high cost of buying and maintaining these machines, which can be difficult for smaller labs or research centers with limited budgets. These systems also require trained staff to operate and maintain them properly, which adds to the overall cost and complexity. Some models may not work with all types of lab containers or setups, making them less flexible for different experiments. In areas with poor infrastructure, power supply problems and limited technical support make it hard to use these machines reliably. Over time, the mechanical parts of the shakers can wear out, leading to higher repair or replacement costs. All these factors make it harder for some labs, especially in developing regions, to adopt automated cell shakers fully.

OPPORTUNITY: Demand increases in areas like drug development

The automated cell shakers market offers many promising opportunities for growth. As demand increases in areas like drug development, cell therapy, and personalized medicine, more labs are looking for efficient and reliable ways to grow cells. There is also growing use of these machines in new fields like food technology, synthetic biology, and environmental research, where they help in fermentation and microbial studies. Advances in technology, such as adding smart features, remote monitoring, and smaller, more flexible designs, are making automated shakers more attractive to a wider range of users. Companies that make these devices can also benefit from rising investments in lab automation and research, as well as partnerships with biotech firms. These trends open up chances for manufacturers to develop better, more innovative equipment and expand into new markets that go beyond traditional pharmaceutical use.

CHALLENGES: Risk of equipment malfunction or breakdown during critical experiments

One significant challenge is the risk of equipment malfunction or breakdown during critical experiments, which can lead to loss of valuable samples and data. Ensuring consistent performance over time requires regular maintenance and quality checks, which can be costly and time-consuming. Additionally, some automated shakers may have limited scalability, making them less suitable for large-scale industrial processes. Integration with existing laboratory information management systems (LIMS) and automation workflows can be complex, requiring additional technical support. There is also the issue of compatibility, as not all shaker models fit every type of container or experimental setup, limiting flexibility. Furthermore, rapid technological advancements mean devices can quickly become outdated, pressuring labs to upgrade frequently. These challenges may cause hesitation among potential buyers and slow down the pace of adoption, especially in resource-limited settings or smaller research facilities.

Global Automated Cell Shakers Market Ecosystem Analysis

The global automated cell shakers market ecosystem comprises manufacturers, component suppliers, research institutions, pharmaceutical companies, and CROs. These stakeholders support applications in drug discovery, cell culture, and diagnostics. Key products include orbital, incubator, and platform shakers, often integrated with automation, IoT, and programmable controls. Technological advancements and growing demand for high-throughput, precision-based research are fueling market growth. North America leads the market, while Asia-Pacific is witnessing rapid expansion due to increased investment in biotechnology and life sciences. The ecosystem emphasizes efficiency, scalability, and innovation in laboratory workflows.

Based on the product, the automated cell shakers segment dominated the automated cell shakers market and is anticipated to grow at a significant CAGR over the forecast period

The segment dominance is attributed to the increasing demand for automated solutions that provide consistent and precise agitation of cell cultures, which is essential for various research and industrial applications. Automated cell shakers improve efficiency by reducing manual intervention and ensuring reproducibility across experiments, making them highly attractive to pharmaceutical companies, biotechnology firms, and research institutions. Technological advancements such as enhanced speed control, better temperature regulation, and compatibility with multiple vessel types further boost their adoption. As the need for scalable and reliable cell culture systems continues to rise, the automated cell shakers segment is expected to maintain its strong market position and grow at a significant compound annual growth rate (CAGR) throughout the forecast period.

Based on the application, the drug development segment dominated the market with the largest revenue share during the forecast period

The segment's strong position is driven by the critical role automated cell shakers play in supporting efficient and reliable cell culture processes essential for drug discovery and development. As pharmaceutical companies focus on developing new drugs and vaccines, the need for consistent cell growth and high-throughput screening increases, boosting demand for automated shaking systems. Additionally, stringent regulatory requirements in drug development encourage the adoption of precise and reproducible laboratory equipment. The continuous advancements in drug research, including biologics and personalized medicine, further contribute to the growing use of automated cell shakers in this segment. As a result, the drug development application is expected to remain the leading contributor to market revenue, maintaining significant growth throughout the forecast period.

North America is anticipated to hold the largest share of the automated cell shakers market during the forecast period

North America is expected to maintain its position as the largest market for automated cell shakers throughout the forecast period. This leadership is driven by the region’s well-established pharmaceutical and biotechnology industries, extensive research infrastructure, and significant investment in life sciences and laboratory automation. The presence of numerous key market players and advanced healthcare facilities further supports the high adoption rate of automated cell shaker technologies. Additionally, strong government funding and favorable regulatory frameworks encourage innovation and the integration of cutting-edge laboratory equipment. Growing demand for drug development, regenerative medicine, and cell-based research in North America continues to fuel the need for efficient and reliable cell culture tools. As a result, the region is anticipated to dominate the global automated cell shakers market and sustain robust growth in the coming years.

Asia Pacific is expected to grow at the fastest CAGR in the automated cell shakers market during the forecast period

The Asia Pacific region is expected to experience the fastest CAGR in the automated cell shakers market during the forecast period. This rapid growth is driven by increasing investments in biotechnology and pharmaceutical research, expanding healthcare infrastructure, and rising government support for life sciences across countries like China, India, Japan, and South Korea. The region’s growing number of research institutions, contract research organizations (CROs), and biopharmaceutical companies is boosting demand for advanced laboratory equipment, including automated cell shakers. Additionally, the focus on developing novel therapies, vaccines, and personalized medicine in the Asia Pacific is encouraging adoption of automated and efficient cell culture technologies. With improving technological capabilities and increasing collaborations between local and global players, the Asia Pacific market is poised to be one of the fastest-growing segments globally throughout the forecast period.

Recent Development

• In April 2024, Eppendorf launched the Multitron incubator shaker, designed for high-precision control over shaking and incubation, increasing its capacity and energy efficiency. This model caters to growing needs in cell culture, protein production, and fermentation in research labs.
• In March 2024, Thermo Fisher Scientific introduced the Heratherm  Automated Shaking Incubator, which integrates shaking and incubation in a compact unit. It offers precise temperature control and adjustable shaking speeds, making it ideal for high-throughput applications and versatile research needs.

Key Market Players

KEY PLAYERS IN THE AUTOMATED CELL SHAKERS MARKET INCLUDE

• Eppendorf AG
• Thermo Fisher Scientific Inc.
• Benchmark Scientific, Inc.
• IKA Works, Inc.
• New Brunswick Scientific (a part of Eppendorf)
• Labnet International, Inc.
• Qinlab Technology Co., Ltd.
• Heidolph Instruments GmbH & Co. KG
• Scientific Industries, Inc.
• Biosan Ltd.
• Others